Standard Packaging Crucial for Regulation of Smokeless Tobacco: Experts

Sep.06.2022
Standard Packaging Crucial for Regulation of Smokeless Tobacco: Experts
Bangladesh health experts emphasize the importance of standard packaging for regulating new smokeless tobacco products.

Experts in Bangladesh’s healthcare industry have stated that standard packaging plays a crucial role in regulating the consumption of new and smokeless tobacco products. Smokeless tobacco products pose a harmful threat to public health that is just as significant as the control of cigarette and alcohol consumption, the experts say.


On Monday, during a seminar held at the Six Seasons Hotel in the capital, it was stated that approximately 22 million people in Bangladesh consume smokeless tobacco, which accounts for 58% of the total tobacco consumption in the country.


During a keynote speech at an event organized by the ARK Foundation, York University, and the Health Economics Research Network (HERN), Kamran Siddiqui, Professor of Global Public Health at the Department of Health Sciences at York University, stated that Bangladesh, India, and Pakistan have unusually high rates of smokeless tobacco usage and prevalence in the world.


Despite a slight decline in cigarette consumption rates in Bangladesh over the past few years, the use of smokeless tobacco has remained almost unchanged. Therefore, now is a crucial time to focus on controlling this type of product. This was emphasized by Professor Kamran at a seminar titled "Addressing Smokeless Tobacco Control Policy in Bangladesh.


Kamran Siddiqui has presented several suggestions to control the use of non-combustible tobacco products:


The removal of seasoning products restrictions, the development of standards and monitoring of tobacco-specific nitrosamines (TSNAs), the introduction of retail licenses and viable alternatives, a strict ban on online or social media advertising, community authorization to enforce the ban on sales to minors, increasing taxes, and linking the minimum price to a pack of 20 cigarettes were discussed at an event hosted by Professor AHM Enayet Hossain, former Director General of the Department of Medical Education, with Professor Shakil Ahmed, Director of the National Tuberculosis Control Program, serving as the keynote speaker.


Dr. Syed Mahfuzul Huq, a national expert of the World Health Organization (WHO), participated as a panelist in a project led by Rumana Huque, Executive Director of the ARK Foundation and Professor of Economics at Dhaka University.


During a seminar, a spokesperson revealed that 84% of smokeless tobacco products in Bangladesh do not have appropriate picture health warnings on their packaging. Even if they do have picture health warnings, they do not comply with regulations. They also pointed out that 30% of the packages have no health warnings at all. In neighboring India, the percentage is only 7%.


Furthermore, 16% of tuberculosis patients in Bangladesh are also tobacco consumers. Therefore, experts suggest that controlling tobacco consumption could play a significant role in controlling tuberculosis.


Statement


This article is compiled from third-party information and is intended for industry professionals for the purpose of exchanging knowledge and insights.


This article does not represent the views of 2FIRSTS and 2FIRSTS is unable to confirm the truthfulness and accuracy of its contents. The translation of this article is solely for industry-related exchange and research purposes.


Due to limitations in translation ability, the translated article may not fully reflect the original text. Please refer to the original text for accuracy.


2FIRSTS aligns completely with the Chinese government's remarks and positions regarding any domestic, Hong Kong, Macao, Taiwan, or international affairs.


The copyright of the compiled information belongs to the original media and author, and if there is any infringement, please contact us to delete it.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
The UK High Court has ordered Chinese vape manufacturer Shenzhen SKE Technology to provide £569,039 ($776,000) in security for costs in its design infringement proceedings against Vapepen London and other defendants over its Crystal Bar vape product. The court did not accept the defendants’ main argument that recovering costs from a China-based company would face significant enforcement obstacles, but found that SKE had not sufficiently disclosed its own financial position. The order is procedural and does not determine the underlying infringement claims.
News
Aug.21
Haypp Report: Women Emerge as a Key Growth Driver in the UK Nicotine Pouch Market
Haypp Report: Women Emerge as a Key Growth Driver in the UK Nicotine Pouch Market
According to Haypp’s 2026 UK Nicotine Report, women are a key growth driver in the UK nicotine pouch market. Overall sales for Haypp and Northerner rose 60% year‑on‑year in 2025, but purchases by women surged 202%, versus 25% for men. Women’s share of consumers jumped from 22% to 40%. The report attributes this to discretion, perceived health benefits, and more gender‑neutral product positioning, suggesting future growth will come from a broader range of adult nicotine users.
Jul.01
EU Tobacco Rules Face Pushback as Analysis Says 90% of Consultation Responses Raised Objections
EU Tobacco Rules Face Pushback as Analysis Says 90% of Consultation Responses Raised Objections
An analysis by We Are Innovation says more than 90% of over 82,000 responses to the European Commission’s public consultation on the Tobacco Products Directive revision raised at least one substantial objection to the proposed regulatory direction.
Jul.13
Haypp Report Shows Nicotine Pouches Gaining Ground as a Vape Alternative in the UK
Haypp Report Shows Nicotine Pouches Gaining Ground as a Vape Alternative in the UK
According to Haypp’s 2026 UK Nicotine Report, nicotine pouches are increasingly replacing both cigarettes and vaping. The UK market grew sharply, with Haypp and Northerner reporting a 60% year‑on‑year sales increase in 2025. Notably, 40% of users adopted pouches to quit vaping, nearly matching the 43% who used them to stop smoking. This indicates pouches are expanding beyond traditional smoking cessation and gaining traction among adults seeking non‑inhalable nicotine alternatives.
Jul.01
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
Data|China’s May Vape Exports Fall 10.3%; January–May Shipments Slip 0.9%
Data|China’s May Vape Exports Fall 10.3%; January–May Shipments Slip 0.9%
China’s vape-related exports fell 10.25% year on year in May 2026, marking a second consecutive monthly decline, although exports recovered modestly from April. January-May exports totaled US$4.018 billion, down 0.86% from a year earlier and broadly in line with 2025 levels.
Special Report
Jun.29